EUVIMEDEUVIMED entdecken
Open Access

Atopic dermatitis, cognitive function and psychiatric comorbidities across early childhood and adolescence in a population-based UK birth cohort

Patrick G Sockler iD, Stephen R Hooper, Katrina Abuabara, Emily Z Ma, Sarah Radtke, Aaron Bao, Elle Kim, Rashelle J Musci, Karin Kartawira, Joy Wan iD

British Journal of Dermatology · 15.03.2024 · 190 (4) · 501-509

DOI: 10.1093/bjd/ljad486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 07.12.2023. Verfasst von Patrick G Sockler und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Dermatology. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Learning Disabilities. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Medical Research Council, Wellcome Trust, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atopic dermatitis (AD) may affect cognitive function, but studies are limited and inconsistent. The effect of AD severity on cognition remains underexplored and few previous studies have examined clinically validated or repeated measures of cognition throughout childhood.

Objectives

To evaluate the relationship of AD activity and severity with validated measures of general cognition in a longitudinal birth cohort.

Methods

We conducted cross-sectional analyses using data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a UK cohort of 14 975 individuals followed prospectively since their birth in 1991–92. AD was assessed 11 times between the age of 6 and 166 months. Mothers were asked if their child had an ‘itchy, dry skin rash in the joints and creases’, and AD status was time-updated accordingly as ‘never’, ‘maybe’, ‘inactive’, ‘active/mild’ or ‘active/moderate–severe’. General cognition [i.e. intelligence quotient (IQ)] was measured at 18, 49, 103 and 186 months of age using the Griffiths Mental Development Scales (GMDS), Wechsler Preschool and Primary Scale of Intelligence (WPPSI), Wechsler Intelligence Scale for Children (WISC) and Wechsler Abbreviated Scale of Intelligence (WASI), respectively. Multivariable linear regression was used to compare IQ with respect to nearest time-updated AD status. Secondary analyses were stratified by the presence or absence of psychiatric or learning disorders. An exploratory longitudinal analysis of IQ across all four outcome assessments was conducted using generalized estimating equations.

Results

No significant associations between AD status and full-scale IQ scores on the GMDS, WPPSI, WISC and WASI were observed after adjustment for sociodemographic factors, atopic comorbidities and sleep characteristics. However, at 8 years of age, WISC Performance IQ was slightly, although statistically significantly, lower among children with active/moderate–severe AD [β coefficient –2.16, 95% confidence interval (CI) –4.12 to –0.19] and Verbal IQ was slightly, but statistically significantly, higher among those with inactive AD (β coefficient 1.31, 95% CI 0.28–2.34) compared with those without AD. Analyses stratified by psychiatric or learning disorders, and exploratory longitudinal analyses of cognition revealed similar findings.

Conclusions

We did not find any clinically meaningful associations between AD activity and severity and general cognitive function during early childhood and adolescence. Future studies should incorporate objective measures of AD severity and investigate outcomes beyond IQ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicLearning DisabilitiesChildFemaleHumansChild, PreschoolAdolescentLongitudinal StudiesBirth CohortCross-Sectional StudiesCognitionUnited Kingdom

Autor:innen und Institutionen

  • Departments of Dermatology.
  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Health Sciences, School of Medicine, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
  • Department of Dermatology, University of California-San Francisco School of Medicine, San Francisco, CA, USA.
  • University of Maryland School of Medicine, Baltimore, MD, USA.
  • Child and Adolescent Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

ORCID-Profile: Patrick G Sockler, Joy Wan

Förderung

  • Medical Research Council
  • Wellcome Trust
  • NIAMS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • UK Medical Research Council
  • University of Bristol
  • Wellcome Trust and Medical Research Council

Zitieren

APA

Sockler, P. G., Hooper, S. R., Abuabara, K., Ma, E. Z., Radtke, S., Bao, A., Kim, E., Musci, R. J., Kartawira, K., & Wan, J. (2024). Atopic dermatitis, cognitive function and psychiatric comorbidities across early childhood and adolescence in a population-based UK birth cohort. British Journal of Dermatology, 190(4), 501-509. https://doi.org/10.1093/bjd/ljad486

Vancouver

Sockler PG, Hooper SR, Abuabara K, Ma EZ, Radtke S, Bao A, et al. Atopic dermatitis, cognitive function and psychiatric comorbidities across early childhood and adolescence in a population-based UK birth cohort. British Journal of Dermatology. 2024;190(4):501-509. doi:10.1093/bjd/ljad486

BibTeX
@article{Sockler2024,
  author = {Sockler, Patrick G and Hooper, Stephen R and Abuabara, Katrina and Ma, Emily Z and Radtke, Sarah and Bao, Aaron and Kim, Elle and Musci, Rashelle J and Kartawira, Karin and Wan, Joy},
  title = {Atopic dermatitis, cognitive function and psychiatric comorbidities across early childhood and adolescence in a population-based UK birth cohort},
  journal = {British Journal of Dermatology},
  year = {2024},
  volume = {190},
  number = {4},
  pages = {501--509},
  doi = {10.1093/bjd/ljad486}
}
Kostenlos starten →